肌缩侧面硬化症伪装成多重系统缩,帕金森症和焦虑症作为最初的表现
Haiyan Tang1, Jianping Yao2, Zhuang Wang1
1Department of Neurology, Huzhou Central Hospital, The Fifth School of Clinical Medicine of Zhejiang Chinese Medical University, The Affiliated Central Hospital of Huzhou University, Huzhou, Zhejiang, People's Republic of China.
Degenerative neurological and neuromuscular disease
|September 16, 2025
概括
这项研究详细介绍了最初被误诊为多系统性缩 (MSA) 的第一个报告的肌缩侧面硬化症 (ALS) 病例. 早期识别特定的肌肉刚性和先进的成像可以帮助区分这些神经退行性疾病.
科学领域:
- 神经科学是一个神经科学.
- 神经学 神经学
- 临床医学 临床医学
背景情况:
- 肌缩侧面硬化 (ALS) 和多重系统缩 (MSA) 是不同的神经退行性疾病.
- 虽然ALS可能伴随着帕金森症,但尚未确切地报告ALS模仿MSA的情况.
- 据报道,初级侧面硬化症 (PLS) 模仿帕金森症.
研究的目的:
- 报告第一个ALS病例被误诊为MSA.
- 分析ALS和MSA之间误诊的原因.
- 确定早期诊断的关键差异化特征.
主要方法:
- 一个患者的病例报告最初被诊断为MSA,后来发展为ALS.
- 文献分析以探索诊断挑战.
- 对临床表现,肌肉刚性特征和神经成像发现的审查 (MR,18F-FDG PET).
主要成果:
- 最初被诊断为MSA的患者五年后表现出较低的运动神经元迹象,导致ALS诊断.
- 肌肉硬性在ALS涉及上部运动神经元损伤,速度依赖的音调增加,在下肢更明显.
- 神经成像揭示了ALS中前额/部缩 (MR) 和前额/部新陈代谢降低与正常的基底质 (18F-FDG PET),使其与MSA区分开来.
结论:
- 这是第一个错误诊断为MSA的ALS病例.
- 没有对多巴胺类药物反应的帕金森症需要对非典型的ALS保持谨慎.
- 特定的肌肉刚性模式和先进的神经成像 (MR,18F-FDG PET) 对于ALS和MSA之间的早期差异诊断至关重要.
相关概念视频
Parkinson's Disease: Overview
1.8K
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
1.8K
Parkinson's Disease: Treatment
987
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
987
Myasthenia Gravis: Overview and Treatment
2.8K
Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
2.8K
Alzheimer's Disease: Overview
1.6K
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
1.6K
Myasthenia Gravis: Diagnostic Tests
1.9K
Myasthenia gravis is an autoimmune condition affecting neuromuscular transmission, causing generalized weakness in skeletal muscles. Initial diagnoses rely on patients' signs, symptoms, and medical history. The challenge lies in distinguishing myasthenia from other muscular dystrophies. An important diagnostic feature is the significant improvement of symptoms after administering anticholinesterase inhibitors.
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
1.9K
Autism Spectrum Disorder
987
Autism spectrum disorder (ASD) is a neurodevelopmental condition marked by persistent deficits in social communication and interaction alongside restrictive and repetitive behaviors or interests. ASD is sometimes accompanied by intellectual impairment.
These core symptoms manifest differently among individuals, ranging from mild to severe. The disorder's complexity extends beyond its clinical presentation, encompassing a diverse range of biological, cognitive, and sociocultural influences.
These core symptoms manifest differently among individuals, ranging from mild to severe. The disorder's complexity extends beyond its clinical presentation, encompassing a diverse range of biological, cognitive, and sociocultural influences.
987


